TY - JOUR
T1 - Preventing smoking initiation or relapse following 8.5weeks of involuntary smoking abstinence in basic military training
T2 - Trial design, interventions, and baseline data
AU - Brandon, Thomas H.
AU - Klesges, Robert C.
AU - Ebbert, Jon O.
AU - Talcott, Gerald W.
AU - Thomas, Fridtjof
AU - Leroy, Karen
AU - Richey, Phyllis A.
AU - Colvin, Lauren
N1 - Funding Information:
The study was funded by the National Heart, Lung, and Blood Institute ( R01 HL95785 ) of the National Institutes of Health , with the title of “Preventing Relapse Following Involuntary Smoking Abstinence.” The trial is registered on clinicaltrials.gov ( NCT01374724 ). The opinions expressed on this document are solely those of the authors and do not represent an endorsement by or the views of the United States Air Force, the Department of Defense, or the United States Government. The authors gratefully acknowledge the support of 2nd Air Force, the leadership branch for training in the United States Air Force.
PY - 2014/5
Y1 - 2014/5
N2 - Smoking cessation is a primary method of reducing excess mortality and morbidity. Unfortunately, the vast majority of cessation attempts end in eventual relapse. Relapse-prevention interventions have shown some success at improving the long-term maintenance of tobacco abstinence among individuals motivated to abstain. However, involuntary tobacco abstinence (e.g., military training, hospitalization, incarceration) presents another opportunity for intervention to prevent relapse. During basic military training (BMT), tobacco use is strictly forbidden in all service branches, but tobacco relapse (and initiation) following BMT is extremely high. This paper reports on the design, intervention development, and baseline characteristics of a randomized controlled trial testing minimal interventions designed to prevent tobacco relapse among United States Air Force (USAF) personnel following BMT. Participants are randomized by squadron to receive either a standard smoking-cessation booklet, a new motivation-based booklet designed specifically for USAF personal, or the latter booklet combined with a brief, face-to-face motivational session. Primary outcomes will be self-reported tobacco use at 12 and 24. month follow-up. Given that the Department of Defense is the world's largest employer, the potential of leveraging involuntary tobacco abstinence during BMT into extended abstinence has substantial public health significance.
AB - Smoking cessation is a primary method of reducing excess mortality and morbidity. Unfortunately, the vast majority of cessation attempts end in eventual relapse. Relapse-prevention interventions have shown some success at improving the long-term maintenance of tobacco abstinence among individuals motivated to abstain. However, involuntary tobacco abstinence (e.g., military training, hospitalization, incarceration) presents another opportunity for intervention to prevent relapse. During basic military training (BMT), tobacco use is strictly forbidden in all service branches, but tobacco relapse (and initiation) following BMT is extremely high. This paper reports on the design, intervention development, and baseline characteristics of a randomized controlled trial testing minimal interventions designed to prevent tobacco relapse among United States Air Force (USAF) personnel following BMT. Participants are randomized by squadron to receive either a standard smoking-cessation booklet, a new motivation-based booklet designed specifically for USAF personal, or the latter booklet combined with a brief, face-to-face motivational session. Primary outcomes will be self-reported tobacco use at 12 and 24. month follow-up. Given that the Department of Defense is the world's largest employer, the potential of leveraging involuntary tobacco abstinence during BMT into extended abstinence has substantial public health significance.
KW - Military
KW - Randomized controlled trial
KW - Relapse-prevention
KW - Smoking
KW - Smoking cessation intervention
KW - Tobacco
UR - http://www.scopus.com/inward/record.url?scp=84897078673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897078673&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2014.03.001
DO - 10.1016/j.cct.2014.03.001
M3 - Article
C2 - 24637237
AN - SCOPUS:84897078673
SN - 1551-7144
VL - 38
SP - 28
EP - 36
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
IS - 1
ER -